Profil
Richard E.
Armer, formerly a Research Director at Lectus Therapeutics Ltd., Principal at Pfizer Inc., Ardana Plc, and Oxagen Ltd., and Chief Scientific Officer at Redx Pharma Plc (2014-2024).
Tidigare kända positioner av Richard E. Armer
| Företag | Position | Slut |
|---|---|---|
| REDX PHARMA LIMITED | Teknisk/Vetenskaplig/F&U Direktör | 2024-04-01 |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Företagsledare/Principal | - |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals products | Företagsledare/Principal | - |
| PFIZER INC. | Företagsledare/Principal | - |
Lectus Therapeutics Ltd.
Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Developed ion channel modulators and therapeutics | Teknisk/Vetenskaplig/F&U Direktör | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals products | Health Technology |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Health Technology |
Lectus Therapeutics Ltd.
Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Developed ion channel modulators and therapeutics | Health Technology |
Redx Pharma Plc
Redx Pharma Plc BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing novel, small molecule and targeted medicines for fibrotic disease | Health Technology |
















